Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation.
作者信息
Chu David C, Abu-Samra Abdel Ghanie, Baird Grayson L, Devers Cynthia, Sweeney Joseph, Levy Mitchell M, Muratore Christopher S, Ventetuolo Corey E
机构信息
Department of Medicine, Boston University Medical Center, Boston, MA, USA.
出版信息
Intensive Care Med. 2015 Feb;41(2):369-70. doi: 10.1007/s00134-014-3574-3. Epub 2014 Dec 3.
Abstract
摘要
相似文献
1
Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation.
Intensive Care Med. 2015 Feb;41(2):369-70. doi: 10.1007/s00134-014-3574-3. Epub 2014 Dec 3.
2
Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Artif Organs. 2017 Feb;41(2):186-192. doi: 10.1111/aor.12737. Epub 2016 Jun 3.
3
Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation.
Clin Lab Med. 2014 Sep;34(3):655-73. doi: 10.1016/j.cll.2014.06.014. Epub 2014 Jul 24.
4
Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
Perfusion. 2017 Apr;32(3):238-244. doi: 10.1177/0267659116678057. Epub 2016 Nov 11.
5
Managing the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation Laboratories.
Semin Thromb Hemost. 2017 Apr;43(3):291-299. doi: 10.1055/s-0036-1593414. Epub 2017 Feb 6.
6
Anticoagulation and Transfusion Therapy in Patients Requiring Extracorporeal Membrane Oxygenation.
J Cardiothorac Vasc Anesth. 2017 Jun;31(3):1051-1059. doi: 10.1053/j.jvca.2016.08.011. Epub 2016 Aug 10.
7
Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
Perfusion. 2020 Jan;35(1):13-18. doi: 10.1177/0267659119850024. Epub 2019 May 23.
8
Low-dose heparin during extracorporeal membrane oxygenation treatment in adults.
Intensive Care Med. 2015 Nov;41(11):2020-1. doi: 10.1007/s00134-015-4015-7. Epub 2015 Aug 14.
9
Anticoagulation for pediatric mechanical circulatory support.
Pediatr Crit Care Med. 2013 Jun;14(5 Suppl 1):S37-42. doi: 10.1097/PCC.0b013e318292dfa7.
10
Prospective Side by Side Comparison of Outcomes and Complications With a Simple Versus Intensive Anticoagulation Monitoring Strategy in Pediatric Extracorporeal Life Support Patients.
Pediatr Crit Care Med. 2017 Nov;18(11):1055-1062. doi: 10.1097/PCC.0000000000001306.
引用本文的文献
1
Decreased bleeding and thrombotic complications on extracorporeal membrane oxygenation support following an updated anticoagulation protocol.
JTCVS Open. 2024 Dec 8;23:199-209. doi: 10.1016/j.xjon.2024.11.019. eCollection 2025 Feb.
2
Inferior vena cava thrombosis in patients undergoing extracorporeal membrane oxygenation: a case series and literature review.
BMC Anesthesiol. 2024 Nov 27;24(1):437. doi: 10.1186/s12871-024-02827-9.
3
Evaluation of an aPTT guided versus a multimodal heparin monitoring approach in patients on extra corporeal membrane oxygenation: A retrospective cohort study.
Perfusion. 2025 Apr;40(3):557-567. doi: 10.1177/02676591241253474. Epub 2024 May 13.
4
Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation.
Crit Care Explor. 2022 Oct 25;4(10):e0776. doi: 10.1097/CCE.0000000000000776. eCollection 2022 Oct.
5
Reduced anticoagulation targets in extracorporeal life support (RATE): study protocol for a randomized controlled trial.
Trials. 2022 May 16;23(1):405. doi: 10.1186/s13063-022-06367-w.
6
Machine learning to predict hemorrhage and thrombosis during extracorporeal membrane oxygenation.
Crit Care. 2020 Dec 10;24(1):689. doi: 10.1186/s13054-020-03403-6.
7
Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation.
Ann Cardiothorac Surg. 2019 Jan;8(1):129-136. doi: 10.21037/acs.2018.07.03.
8
Focus on transfusion, bleeding and thrombosis.
Intensive Care Med. 2016 Dec;42(12):1859-1861. doi: 10.1007/s00134-016-4608-9. Epub 2016 Oct 25.
9
Venovenous extracorporeal membrane oxygenation for acute respiratory failure : A clinical review from an international group of experts.
Intensive Care Med. 2016 May;42(5):712-724. doi: 10.1007/s00134-016-4314-7. Epub 2016 Mar 23.
10
Low-dose heparin during extracorporeal membrane oxygenation treatment in adults.
Intensive Care Med. 2015 Nov;41(11):2020-1. doi: 10.1007/s00134-015-4015-7. Epub 2015 Aug 14.
本文引用的文献
1
Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.
Pediatr Crit Care Med. 2014 May;15(4):e175-82. doi: 10.1097/PCC.0000000000000101.
2
Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients.
Perfusion. 2014 Sep;29(5):456-61. doi: 10.1177/0267659114524264. Epub 2014 Feb 25.
3
Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.
Pediatr Crit Care Med. 2014 Feb;15(2):e72-9. doi: 10.1097/PCC.0000000000000028.
4
Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin.
Ann Pharmacother. 2013 Feb;47(2):151-8. doi: 10.1345/aph.1R635. Epub 2013 Feb 5.
5
Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.
Pharmacotherapy. 2012 Jun;32(6):546-58. doi: 10.1002/j.1875-9114.2011.01049.x. Epub 2012 Apr 24.
Zotero 插件